Document ID: FDA-2012-N-0001-0155
Agency: fda
Document Type: Notice
Title: Advisory Committees; 2013 Tentative Schedule Meeting
Posted Date: 2013-01-02T05:00Z

[Federal Register Volume 78, Number 1 (Wednesday, January 2, 2013)]
[Notices]
[Pages 104-105]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-31475]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Advisory Committees; Tentative Schedule of Meetings for 2013

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a 
tentative schedule of forthcoming meetings of its public advisory 
committees for 2013. During 1991, at the request of the Commissioner of 
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) 
conducted a study of the use of FDA's advisory committees. In its final 
report, one of the IOM's recommendations was for the Agency to publish 
an annual tentative schedule of its meetings in the Federal Register. 
This publication implements the IOM's recommendation.

FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 32, rm. 5290, Silver Spring, MD 20993, 
301-796-8220.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, 
undertook a study of the use of FDA's advisory committees. In its final 
report in 1992, one of the IOM's recommendations was for FDA to adopt a 
policy of publishing an advance yearly schedule of its upcoming public 
advisory committee meetings in the Federal Register; FDA has 
implemented this recommendation. The annual publication of tentatively 
scheduled advisory committee meetings will provide both advisory 
committee members and the public with the opportunity, in advance, to 
schedule attendance at FDA's upcoming advisory committee meetings. 
Because the schedule is tentative, amendments to this notice will not 
be published in the Federal Register. However, changes to the schedule 
will be posted on the FDA advisory committees' Internet site located at 
http://www.fda.gov/AdvisoryCommittees/default.htm. FDA will continue to 
publish a Federal Register notice 15 days in advance of each upcoming 
advisory committee meeting, to announce the meeting (21 CFR 14.20).
    The following list announces FDA's tentatively scheduled advisory 
committee meetings for 2013. You may also obtain up-to-date information 
by calling the Advisory Committee Information Line, 1-800-741-8138 
(301-443-0572 in the Washington, DC area) or on the FDA Internet Web 
site under our 2013 tentative scheduled meeting listing at http://www.fda.gov/AdvisoryCommittees/Calendar/ucm153468.htm.

                                 Table 1
------------------------------------------------------------------------
             Committee name              Tentative date(s) of meeting(s)
------------------------------------------------------------------------
                       OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory Committee...........  March 14-15, September 19-20.
Risk Communication Advisory Committee..  February 11-12, April 29-30,
                                          August 15-16, December 16-17.
Science Board to FDA...................  February 27, June 24, November
                                          20.
------------------------------------------------------------------------
              CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products Advisory Committee.  November 5-6.
Blood Products Advisory Committee......  February 12-13, April 8-9,
                                          August 1-2.
Cellular, Tissue and Gene Therapies      January 15, April 17-18, June
 Advisory Committee.                      27-28, October 24-25.
Transmissible Spongiform                 March 14-15.
 Encephalopathies Advisory Committee.
Vaccines and Related Biological          February 27, May 8-9 or July 17-
 Products Advisory Committee.             18 (Backup date), September 18-
                                          19, November 13-14.
------------------------------------------------------------------------
                 CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Analgesic Drug Products   Date(s), if needed, to be
 Advisory Committee.                      determined.
Anti-Infective Drugs Advisory Committee  Date(s), if needed, to be
                                          determined.
Antiviral Drugs Advisory Committee.....  May and October dates to be
                                          determined.
Arthritis Advisory Committee...........  July or August and fall dates
                                          to be determined.
Cardiovascular and Renal Drugs Advisory  April 17 and other date(s) to
 Committee.                               be determined.
Dermatologic and Ophthalmic Drugs        Date(s), if needed, to be
 Advisory Committee.                      determined.
Drug Safety and Risk Management          January 24-25, March 5.
 Advisory Committee.
Endocrinologic and Metabolic Drugs       January 10, July, and August
 Advisory Committee.                      dates to be determined.
Gastrointestinal Drugs Advisory          March 19 and other date(s) to
 Committee.                               be determined.
Medical Imaging Drugs Advisory           February 14 and May date to be
 Committee.                               determined.
Nonprescription Drugs Advisory           Date(s), if needed, to be
 Committee.                               determined.
Oncologic Drugs Advisory...............  April 5, May, June, July,
Committee..............................   September date(s) to be
                                          determined.
Pharmacy Compounding Drugs Advisory      Date(s), if needed, to be
 Committee.                               determined.
Peripheral and Central Nervous System    May 22.
 Drugs Advisory Committee.
Advisory Committee for Pharmaceutical    Date(s), if needed, to be
 Science and Clinical Pharmacology.       determined.
Psychopharmacologic Drugs Advisory       Date(s), if needed, to be
 Committee.                               determined.
Pulmonary[dash]Allergy Drugs Advisory    January 29-30, March 7.
 Committee.
Advisory Committee for Reproductive      March 4-5, July 9.
 Health Drugs.
------------------------------------------------------------------------

[[Page 105]]

 
               CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
Medical Devices Advisory Committee
 (Comprised of 18 Panels)
------------------------------------------------------------------------
Anesthesiology and Respiratory Therapy   Date(s), if needed, to be
 Devices Panel.                           determined.
Circulatory System Devices Panel.......  May 17, May 24, June 27,
                                          September 27, November 22.
Clinical Chemistry and Clinical          April 25.
 Toxicology Devices Panel.
Dental Products Panel..................  Date(s), if needed, to be
                                          determined.
Ear, Nose, and Throat Devices Panel....  July 12.
Gastroenterology-Urology Devices Panel.  April 24, May 16.
General and Plastic Surgery Devices      June 13.
 Panel.
General Hospital and Personal Use        June 28, August 30.
 Devices Panel.
Hematology and Pathology Devices Panel.  Date(s), if needed, to be
                                          determined.
Immunology Devices Panel...............  Date(s), if needed, to be
                                          determined.
Medical Devices Dispute Resolution       Date(s), if needed, to be
 Panel.                                   determined.
Microbiology Devices Panel.............  June 14.
Molecular and Clinical Genetics Panel..  September 13.
Neurological Devices Panel.............  February 22.
Obstetrics and Gynecology Devices Panel  September 20.
Ophthalmic Devices Panel...............  June 14, August 23.
Orthopaedic and Rehabilitation Devices   April 5, September 26.
 Panel.
Radiological Devices Panel.............  September 12.
Device Good Manufacturing Practice       April 11.
 Advisory Committee.
National Mammography Quality Assurance   October 25.
 Advisory Committee.
Technical Electronic Product Radiation   Date(s), if needed, to be
 Safety Standards Committee.              determined.
------------------------------------------------------------------------
              CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee................  July 15-16, August 29-30,
                                          September 23-24.
------------------------------------------------------------------------
                       CENTER FOR TOBACCO PRODUCTS
------------------------------------------------------------------------
Tobacco Products Scientific Advisory     Feb 11-12, April 30-May 1.
 Committee.
------------------------------------------------------------------------
                     CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine Advisory Committee.  Date(s), if needed, to be
                                          determined.
------------------------------------------------------------------------
            NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)
------------------------------------------------------------------------
Science Advisory Board to NCTR.........  December 10-11.
------------------------------------------------------------------------

    Dated: December 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-31475 Filed 12-31-12; 8:45 am]
BILLING CODE 4160-01-P